Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

Press Releases

PDA and PIC/S Offer ICH Q7 Training in Hyderbad and Ahmedabad India

For Immediate Release:
07/27/2015
Media Inquiries:
Walt Morris
/ morris@pda.org /
301-656-5900, x. 148

Bethesda, Md., July 27, 2015 – The Parenteral Drug Association (PDA) is teaming up with the Pharmaceutical Inspection Co-operation Scheme (PIC/S) to conduct training for pharmaceutical professionals in Hyderbad and Ahmedabad India on the International Conference on Harmonisation quality guideline Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.

India hosts a rapidly growing active pharmaceutical ingredient (API) industry, which is growing at 10% annually and now accounts for approximately 20% of the global marketplace, which is valued at over $100 billion.

API producers must meet GMP requirements, and the ICH Q7 guideline is the most widely accepted standard globally. PDA has a long history of educating the industry globally on this guidance, and by teaming with PIC/S, will deliver two-day courses in Hyderbad and Ahmedabad that cover how the document has been interpreted and enforced.

The 2015 PDA PIC/S Training Course includes members of the original ICH Expert Work Group (EWG) and current Implementation Working Group (IWG) who are asked to develop Q&As to facilitate implementation.